These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 22867540)
21. [Validation of pharmaceutical quality of a [6,6-(2)H(2)]-glucose parenteral solution used for insulin-resistance measurement during human clinical trials]. Blond E; Diouf E; Tall ML; Sauvinet V; Desage M; Despiau MC; Laville M; Pirot F; Goudable J; Pivot C Ann Pharm Fr; 2011 Nov; 69(6):306-16. PubMed ID: 22115134 [TBL] [Abstract][Full Text] [Related]
22. [Standard doses applied to preparations of injectable drugs and their reconstitution in the hospital: methodology and implementation]. Hennebicq S; Secretan PH; Carrez L; Hecq JD J Pharm Belg; 2014 Mar; (1):42-54. PubMed ID: 24804393 [TBL] [Abstract][Full Text] [Related]
23. Long-term stability of the hydrochlorides of tramadol and alizapride in dextrose 5% polyolefin bag at 5+/-3 degrees C. Athanasopoulos A; Hecq JD; Vanbeckbergen D; Jamart J; Galanti L Ann Pharm Fr; 2010 May; 68(3):157-62. PubMed ID: 20569772 [TBL] [Abstract][Full Text] [Related]
24. Characterization of a potential medium for 'biorelevant' in vitro release testing of a naltrexone implant, employing a validated stability-indicating HPLC method. Iyer SS; Barr WH; Karnes HT J Pharm Biomed Anal; 2007 Feb; 43(3):845-53. PubMed ID: 17045445 [TBL] [Abstract][Full Text] [Related]
25. Sorption of amiodarone to polyvinyl chloride infusion bags and administration sets. Weir SJ; Myers VA; Bengtson KD; Ueda CT Am J Hosp Pharm; 1985 Dec; 42(12):2679-83. PubMed ID: 4083289 [TBL] [Abstract][Full Text] [Related]
26. Evaluation of different preparation methods for a preservative free triamcinolone acetonide preparation for intravitreal administration: a validated stability indicating HPLC-method. Korodi T; Lachmann B; Kopelent-Frank H Pharmazie; 2010 Dec; 65(12):860-6. PubMed ID: 21284253 [TBL] [Abstract][Full Text] [Related]
27. Stability issues of parenteral chemotherapy drugs. de Lemos ML; Hamata L J Oncol Pharm Pract; 2007 Mar; 13(1):27-31. PubMed ID: 17621564 [TBL] [Abstract][Full Text] [Related]
28. Stability of atenolol in an extemporaneously compounded oral liquid. Garner SS; Wiest DB; Reynolds ER Am J Hosp Pharm; 1994 Feb; 51(4):508-11. PubMed ID: 8017418 [TBL] [Abstract][Full Text] [Related]
29. Physical stability of highly concentrated injectable drugs solutions used in intensive care units. Closset M; Hecq JD; Soumoy L; Simar J; Gonzalez E; Charlet L; Declave C; Gillet P; Galanti L Ann Pharm Fr; 2017 May; 75(3):185-188. PubMed ID: 28209389 [TBL] [Abstract][Full Text] [Related]
30. [Formulation and stability study of sucred solutions for a clinical trial in neonates]. Senis-Loiseau C; Vaillant C; Markiewicz-Massy A; Torck M; Thielmans B Ann Pharm Fr; 2003 Nov; 61(6):425-30. PubMed ID: 14639195 [TBL] [Abstract][Full Text] [Related]
31. [Monitoring medication errors in personalised dispensing using the Sentinel Surveillance System method]. Pérez-Cebrián M; Font-Noguera I; Doménech-Moral L; Bosó-Ribelles V; Romero-Boyero P; Poveda-Andrés JL Farm Hosp; 2011; 35(4):180-8. PubMed ID: 21571564 [TBL] [Abstract][Full Text] [Related]
32. Centralized intravenous additive services (CIVAS): the state of the art in 2010. Hecq JD Ann Pharm Fr; 2011 Jan; 69(1):30-7. PubMed ID: 21296215 [TBL] [Abstract][Full Text] [Related]
33. Evaluation of the Physicochemical Stability of Amiodarone Hydrochloride in Syringes for the Intensive Care Unit. Lardinois B; Dimitriou A; Delcave C; Jamart J; Bihin B; Soumoy L; Hecq JD; Galanti LM Int J Pharm Compd; 2019; 23(2):163-166. PubMed ID: 31085782 [TBL] [Abstract][Full Text] [Related]
34. Chemical stability of oseltamivir in oral solutions. Albert K; Bockshorn J Pharmazie; 2007 Sep; 62(9):678-82. PubMed ID: 17944321 [TBL] [Abstract][Full Text] [Related]
35. Stability of cefuroxime in 1% and 5% buffered eye drops determined with HPLC method. Kodym A; Wiśniewski A; Knioła D; Olejniczak M Acta Pol Pharm; 2011; 68(4):555-64. PubMed ID: 21796938 [TBL] [Abstract][Full Text] [Related]
36. Pharmacy program for improved handling of antineoplastic agents. Scott SA; Schrott DB; Loesch GA Am J Hosp Pharm; 1983 Jul; 40(7):1179-82. PubMed ID: 6881156 [TBL] [Abstract][Full Text] [Related]
37. Formulation and in vitro evaluation of cysteamine hydrochloride viscous solutions for the treatment of corneal cystinosis. Bozdağ S; Gümüş K; Gümüş O; Unlü N Eur J Pharm Biopharm; 2008 Sep; 70(1):260-9. PubMed ID: 18590953 [TBL] [Abstract][Full Text] [Related]
38. 2006 national clinical pharmacy services survey: clinical pharmacy services, collaborative drug management, medication errors, and pharmacy technology. Bond CA; Raehl CL Pharmacotherapy; 2008 Jan; 28(1):1-13. PubMed ID: 18154468 [TBL] [Abstract][Full Text] [Related]
39. Effects of compounding and storage conditions on stability of pergolide mesylate. Davis JL; Kirk LM; Davidson GS; Papich MG J Am Vet Med Assoc; 2009 Feb; 234(3):385-9. PubMed ID: 19210262 [TBL] [Abstract][Full Text] [Related]
40. Decentralization of pharmaceutical services in a large hospital complex. Sateren LA; Streit RJ Am J Hosp Pharm; 1986 Nov; 43(11):2785-9. PubMed ID: 3799615 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]